logo

Hikma Pharmaceuticals Plc (HIK.L)



Trade HIK.L now with
  Date
  Headline
10/22/2021 8:03:28 AM Hikma Donates 50,000 Doses Of Injectable Naloxone - A Treatment For Reversing Opioid Overdoses
9/27/2021 2:11:59 AM Hikma Pharma Agrees To Acquire Custopharm From Water Street Healthcare Partners
9/27/2021 2:08:09 AM Hikma Pharma To Acquire Custopharm From Water Street Healthcare Partners
8/27/2021 8:38:15 AM Bio-Thera And Hikma Announce Exclusive Agreement To Commercialize BAT2206
8/6/2021 2:45:07 AM Hikma Pharma HY Profit Rises
8/6/2021 2:08:07 AM Hikma Pharma H1 Core Basic EPS 96.5c Vs 85.3c Last Year
8/4/2021 8:03:14 AM Hikma Announces The Launch Of KLOXXADO Nasal Spray 8mg In U.S.
6/9/2021 8:02:54 AM Hikma Pharma Names Patrick Genestin VP, Business Development, Generics
4/30/2021 2:08:16 AM Hikma: FDA Approves KLOXXADOTM Nasal Spray 8mg For Emergency Treatment Of Known Or Suspected Opioid Overdose
4/30/2021 2:06:55 AM Hikma Pharma Says FY View Unchanged; Remain Confident In Its Ability To Deliver Consistent Long-term Growth
4/29/2021 8:07:29 AM Melinta And Hikma Sign Licensing Deal For Two Novel Anti-Infectives For Middle East And North Africa Region
4/21/2021 2:05:44 AM Hikma Pharma Resumes Launch Of Generic Version Of GlaxoSmithKline's Advair DiskusĀ®1 In The US
3/11/2021 8:40:13 AM Hikma Not To Launch Mandatory Tender Offer Process To Acquire Shares In GlaxoSmithKline SAE Egypt